Clinical trial
Retrospective Chart Review of Patients With PAH or Inoperable/Persistent/Recurrent CTEPH Who Transition Their PH Treatment to Adempas
NCT02545465 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Chart Review of Patients With PAH or Inoperable/Persistent/Recurrent CTEPH Who Transition Their PH Treatment to Adempas
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 15, 2015
- Completion date
- August 31, 2016
- Enrollment
- 125 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.